REQUEST A DEMO
Total
USD $0.00
Search more companies

Union Korea Pharm Co.,Ltd. (Wonju) (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Union Korea Pharm Co.,Ltd. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Union Korea Pharm Co.,Ltd. (Wonju) is based in South Korea. The head office is in Wonju. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on August 10, 1985. The total number of employees is currently 181 (2024). From the latest financial highlights, Union Korea Pharm Co.,Ltd. (Wonju) reported a net sales revenue drop of 18.82% in 2024. A negative growth of 20.68% was recorded in its total assets. In, 2024, the company’s net profit margin decreased by 11.96%.

Headquarters
246, Munmakgongdan-Gil, Munmak-Eup, Wonju-Si, Gangwon-Do
Wonju; Gangwon;

Contact Details: Purchase the Union Korea Pharm Co.,Ltd. (Wonju) report to view the information.

Website: http://www.ukp.co.kr

Basic Information
Total Employees:
Purchase the Union Korea Pharm Co.,Ltd. (Wonju) report to view the information.
Outstanding Shares:
Purchase the Union Korea Pharm Co.,Ltd. (Wonju) report to view the information.
Registered Capital:
Purchase the Union Korea Pharm Co.,Ltd. (Wonju) report to view the information.
Financial Auditors:
Purchase the Union Korea Pharm Co.,Ltd. (Wonju) report to view the information.
Incorporation Date:
August 10, 1985
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
12%
Purchase this report to view the information.
9.5%
Purchase this report to view the information.
9.1%
Subsidiaries
(주)한국유니온생명과학
Company Performance
Financial values in the chart are available after Union Korea Pharm Co.,Ltd. (Wonju) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-18.82%
Total Operating Revenue
-21.83%
Operating Profit
-84.23%
EBITDA
N/A
Net Profit/Loss for the Period
-14.96%
Total Assets
-20.68%
Total Equity
-72.8%
Operating Profit Margin
-24.4%
Net Profit Margin
-11.96%
Return on Equity (ROE)
-193.15%
Debt / Equity
161.08%
Quick Ratio
-0.28%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?